No Data
No Data
Emerging markets stock digest: Jelbins significantly extended, Rainfall Sunlight hit the daily limit
<150A> JSH 621 -1 deadlock. It has been announced that a new branch of the home medical care business, 'Visiting Nurse Station Cordiale Edogawa Sales Office,' has been established in Edogawa-ku, Tokyo. 'Visiting Nurse Station Cordiale' is a psychiatric home visit medical support service office. The number of psychiatric patients is increasing year by year, and the demand for home medical care that can be received at home is expanding, so efforts are being made to expand the area. <206A> PRISMBio 415 -39
Heartseed and others continue to rank in, with the review of the first case in the high-dose group completed in a study of iPS cell-derived cardiomyocytes from other households.
Heartseed <219A> ranked in (as of 10:32). Significantly extended. After the end of the previous day's trading, it was announced that the safety review by the safety evaluation committee of the first high-dose group for severe heart failure associated with ischemic heart disease using iPS cell-derived myocardial spheres (HS-001) in the phase 1/2 trial (LAPiS trial) was completed. Following the completion of the review, it became possible to continue dosing in the high-dose group. Top changes in volume ratio [October 1st 10:32 current] (last 5
Volume change rate ranking (9 o'clock) - Rain, wind, sun, Jellybee, etc. ranked in.
In the volume change rate ranking, by comparing the average volume of the past 5 days with the volume on the delivery date, you can understand the interests of market participants such as market trends. Top volume change rate [As of 9:32 on October 2] (comparison with the average volume of the past 5 days) Stock Code Stock Name Volume 5-Day Average Volume Volume Change Rate Stock Price Change Rate <3070> Jellybee 3127900 107185.08 305.84% 0.19
October 1st [Today's investment strategy]
[Fisco Selected Stocks] [Material Stocks] Nexera Pharma <4565> 1226 yen (10/1) Drug discovery venture. Former Sosei Group. Its subsidiary Nexera Pharma Japan has announced the signing of a partnership agreement with Shionogi <4507> regarding the distribution and sales of the insomnia treatment drug "Cubick Tablets" in Japan, and resolved its sales efforts with Mochida Pharmaceutical <4534>. Shionogi will independently conduct distribution and sales activities in Japan. [Emerging Markets]
Tsubota Lab, Jelly Beans, and more
Safety evaluation committee review for the first example of high-dose administration of Heartseed HS-001 LAPiS completed <2586> Large-scale exercise of the 15th new subscription rights for Flottah Flottah (with exercise price adjustment clause), grant of shares from day 1, 3.37 million shares <3070> Jellybeans metaverse, game, software, and hardware development handled by Metacity and signing of the LORD OF DRAGONS Japan general agency agreement <4883>
Volume change rate ranking (10 o'clock) - Melco, Bushiroad, etc. are ranked.
※In the volume change rate ranking, you can understand the interest of market participants, such as trends in trading, by comparing the average volume of the past 5 days with the volume on the delivery day. ■Top volume change rate [As of 10:32 on September 27] (Comparison with average volume of the past 5 days) Stock code Stock name Volume 5-day average volume Volume change rate Price change rate <1487> U.S. Treasury HE 22624 51212.14 225.98% 0%
No Data
No Data